Investors with a lot of money to spend have taken a bullish stance on Pfizer PFE.
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PFE, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 21 options trades for Pfizer.
This isn't normal.
The overall sentiment of these big-money traders is split between 52% bullish and 38%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $112,000, and 20, calls, for a total amount of $1,115,688.
What's The Price Target?
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $23.0 to $37.5 for Pfizer during the past quarter.
Volume & Open Interest Development
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Pfizer's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Pfizer's significant trades, within a strike price range of $23.0 to $37.5, over the past month.
Pfizer 30-Day Option Volume & Interest Snapshot
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PFE | CALL | TRADE | BULLISH | 06/18/26 | $7.65 | $7.65 | $7.65 | $23.00 | $153.0K | 392 | 220 |
| PFE | CALL | SWEEP | NEUTRAL | 01/17/25 | $5.25 | $5.0 | $5.1 | $25.00 | $124.4K | 33.2K | 503 |
| PFE | PUT | TRADE | BEARISH | 06/21/24 | $1.13 | $1.09 | $1.12 | $30.00 | $112.0K | 23.3K | 74 |
| PFE | CALL | TRADE | BULLISH | 01/17/25 | $2.0 | $1.95 | $2.0 | $30.00 | $100.0K | 45.5K | 1.7K |
| PFE | CALL | SWEEP | BULLISH | 07/19/24 | $0.76 | $0.73 | $0.76 | $30.00 | $76.0K | 17.1K | 2.8K |
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
After a thorough review of the options trading surrounding Pfizer, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Pfizer's Current Market Status
- With a trading volume of 20,549,707, the price of PFE is up by 1.99%, reaching $29.23.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 57 days from now.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Pfizer, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
